Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

JB CHEMICALS & PHARMACEUTICALS LTD.

NSE : JBCHEPHARMBSE : 506943ISIN CODE : INE572A01036Industry : Pharmaceuticals & DrugsHouse : Private

BSE1689.054.05 (+0.24 %)

PREV CLOSE ( ) 1685.00

OPEN PRICE ( ) 1675.05

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 15279

TODAY'S LOW / HIGH ( )1667.35 1691.00

52 WK LOW / HIGH ( )1303 2029

NSE1687.602.8 (+0.17 %)

PREV CLOSE( ) 1684.80

OPEN PRICE ( ) 1685.80

BID PRICE (QTY) 1687.60 (495)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 322750

TODAY'S LOW / HIGH( ) 1667.40 1691.50

52 WK LOW / HIGH ( )1385.75 2030

BSE NSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 18-12 1976

Management Info

Arun Duggal - Chairman - Managing Director

Registered Office

Address Neelam Centre, ' B 'wing,4th Floor, Hind Cycle Road,Worli,
Mumbai,
Maharashtra-400030

Phone 022- 2482 2222

Email secretarialijftjbpharma.com

Website www.jbpharma.com

Registrars Details

Datamatics Business Solutions Ltd.

Plot No. A 16 & 17,Part B Cross Lane,MIDC, Andheri (E),Mumbai

Listing : BSE, NSE

NEWS

14Jul Draft Letter of Offer
NovaaOne Capital Pvt Ltd ("Manager to the Open Offer") has submitted to..

04Jul Updates on Open Offer
NovaaOne Capital Pvt Ltd ("Manager to the Open Offer") has submitted to..

30Jun Announcement under Regulation 30 (LOD
Public Announcement of open offer for acquisition of Company''s equity s..

25Jun J. B. Chemicals & Pharmaceuticals gets
J. B. Chemicals & Pharmaceuticals has received approval from United..

18Jun JB Chemicals & Pharmaceuticals informs
JB Chemicals & Pharmaceuticals has informed that the Company has pub..

Financials

Rs. in Millions

	QTR Mar 25	ANNUAL 25
Net Profit	1498	6525.4
Gross Profit	1991.7	8771.1
Operating Profit	2445.1	10526.8
Net Sales	9013.4	37229.2

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Abbott India (BSE) 34192.50 (0.40%)	M.Cap ( in Cr)72656.68
Emcure Pharma (BSE) 1425.40 (5.00%)	M.Cap ( in Cr)27012.52
Sanofi Cons. Health (BSE) 5112.20 (1.27%)	M.Cap ( in Cr)11773.71
Bharat Parenterals (BSE) 1603.75 (3.47%)	M.Cap ( in Cr)1105.30
BDH Inds (BSE) 349.80 (17.21%)	M.Cap ( in Cr)201.39

Shareholding Pattern

	PROMOTERS	47.73%
	MUTUAL FUNDS/UTI	16.27%
	NON-INSTITUTION	14.88%
	FI/BANKS/INSURANCE	2.68%
	GOVERNMENT	0%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
Kotak Healthcare Fu...	3.52
PGIM India Healthca...	3.16
Aditya Birla SL Pha...	2.82
LIC MF Healthcare F...	2.82
Kotak MNC Fund-Reg(G)	2.73
Mirae Asset Healthc...	2.71
Sundaram LT Tax Adv...	2.57

Risk Disclosures on Derivatives

Smart Quotes

JB CHEMICALS & PHARMACEUTICALS LTD.